openPR Logo
Press release

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growing At A CAGR Of 6.5% From 2021 To 2031

03-06-2023 04:03 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Insight Services

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market was valued at USD 1.5 billion in 2021 and it is anticipated to grow up to USD 2.9 billion by 2031, at a CAGR of 6.5% during the forecast period.

Read more about Endoscopic Retrograde Cholangiopancreatography market here: https://www.globalinsightservices.com/reports/endoscopic-retrograde-cholangiopancreatography-ercp-market/

In order to diagnose and treat disorders of the bile and pancreatic ducts, endoscopic retrograde cholangiopancreatography (ERCP) combines endoscopy with x-ray technology. The use of precut sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) may increase the likelihood that a cannulation will be successful, but it is associated with an increased risk of post-ERCP pancreatitis. For patients with difficult biliary access, applying precut sphincterotomy involving sphincterotomes sooner rather than later may reduce this risk.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10278

Major Players in the global endoscopic cholangiopancreatography Market

The key players studied in the market are Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), B. Braun Melsungen AG (Germany), Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US), Changzhou Health Microport Medical Device Co., LTD. (China), Medi-Globe GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), Huger Medical Instrument Co., Ltd. (China), IntroMedic Co., Ltd. (Republic of Korea), SonoScape Medical Corporation (China), Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. (China), Ottomed (India), Kimberly-Clark Corporation (US), Shaili Endoscopy (India).

Market Segments

By Product

Endoscopes
Endotherapy Devices
Visualization Systems
Energy Devices
Others
By Procedure

Biliary Sphincterotomy
Biliary Stenting
Biliary Dilatation
Pancreatic Duct Stenting
Pancreatic Duct Dilatation
Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10278

Market Trends and Drivers

The incidence of cancer is rising globally today. Cancer was the second-leading cause of death worldwide in 2018, accounting for 9.6 million fatalities, according to the WHO. The American Cancer Society predicts that in 2022, there will be roughly 41,260 new instances of liver cancer and intrahepatic bile duct cancer detected in the US. Since 1980, the incidence of liver cancer has more than tripled, while the fatality rate has more than doubled. About 60,430 new cases of the pancreatic disease were identified in the US in 2021.

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10278

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growing At A CAGR Of 6.5% From 2021 To 2031 here

News-ID: 2961070 • Views:

More Releases from Global Insight Services

Helium Gas Market: Expansion Fueled by Increasing Applications in Cryogenics, Aerospace, and Advanced Manufacturing
Helium Gas Market: Expansion Fueled by Increasing Applications in Cryogenics, Ae …
The Helium Gas Market is evolving rapidly as industries worldwide continue to rely on helium for its unique properties, including low boiling point, inertness, and high thermal conductivity. This rare noble gas is essential across healthcare, electronics, aerospace, and scientific research. As technological innovation accelerates, the Helium Gas Market continues to play a vital role by supporting advanced manufacturing processes and critical medical applications. From MRI machines to semiconductor fabrication,
Heavy Lift Helicopters Market: Growth Supported by Adoption of Advanced Rotorcraft for Heavy Cargo and Specialized Missions | Overall Study Report Till 2035
Heavy Lift Helicopters Market: Growth Supported by Adoption of Advanced Rotorcra …
The Heavy-lift Helicopter Market continues to gain traction as industries and defense organizations increasingly rely on advanced aerial transport capabilities. Heavy-lift helicopters are engineered to carry substantial payloads, support remote operations, and enhance mobility across the construction, military, oil and gas, and emergency response sectors. With rising global tensions, expanding infrastructure projects, and rapid modernization of aviation fleets, the Heavy-lift Helicopter Market is entering a phase of strong, technology-driven growth.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Key Players: Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2034 At 6.9% Cagr. Key Players: Activeviam, Sas Risk Management, Fiserv.
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.

All 5 Releases


More Releases for ERCP

North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions. Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging
EU5 ERCP and PTC Devices Market to Reach USD 1.5 Billion by 2034
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) are essential diagnostic and therapeutic procedures used to treat conditions affecting the biliary and pancreatic ducts, such as gallstones, tumors, strictures, and obstructions. ERCP is a non-surgical procedure that combines endoscopy and fluoroscopy to evaluate the pancreatic and bile ducts, while PTC is used in cases where ERCP is not feasible, allowing direct visualization of the bile ducts via a needle
ERCP Device Market Size And Global Industry Forecast 2034
"The Endoscopic Retrograde Cholangiopancreatography (ERCP) device market is currently valued at approximately $1.2 billion in 2024. The market is projected to grow significantly, reaching an estimated $2.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034." Exactitude Consultancy., Ltd. released a research report titled "ERCP Device Market". This report covers the global ERCP Device market sales, sales volume, price,
Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by …
North America accounted for the largest share of the ERCP market. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this. According to the new market research report "Endoscopic Retrograde Cholangiopancreatography/ERCP Market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-retrograde-cholangiopancreatography-ercp-market-170242954.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket] by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy),
ERCP Catheter Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growt …
ERCP Catheter Market The global ERCP Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for ERCP Catheter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030. Asia-Pacific market for ERCP Catheter is
Asia-Pacific ERCP Devices Market: Navigating Growth and Innovation
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a